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ABSTRACT
Female ageing represents the biological process of struc-
tural and functional changes in endocrine cells and tissues, 
as well as in pituitary hormone-producing cells. In addition 
to the hypothalamic releasing hormones, estradiol plays a 
signiﬁ cant role in the regulation of the synthesis/secretion 
of pituitary hormones and is still used therapeutically for 
menopausal symptoms. Th e eﬀ ects of ageing or ovariectomy 
and synthetic estradiol application under these circum-
stances were evaluated in pituitary hormone-producing 
cells of female rats (animal models of menopause); i.e., 
the following cells were observed: gonadotropes (FSH and 
LH), thyrotropes (TSH), somatotropes (GH), mammotropes 
(PRL) and corticotropes (ACTH). Th e cells were immunos-
tained and histologically analysed. Th e ELISA method was 
used for hormonal analyses. Ageing was found to cause di-
verse, commonly reductive changes regarding the volume, 
number and secretion of menopausal rat pituitary hor-
mone-producing cells, except for PRL cells that exhibit sig-
niﬁ cantly increased numbers and intensiﬁ ed secretion. Af-
ter the treatment of middle-aged female rats with estradiol, 
the absolute and relative pituitary weights signiﬁ cantly in-
creased in comparison with the control females. Histologi-
cal parameters such as the cell and volume density of PRL 
and ACTH cells were signiﬁ cantly increased compared with 
the control values. Th e mentioned parameters of FSH, LH, 
GH, and occasionally TSH cells after estradiol treatment 
signiﬁ cantly decreased in comparison with the controls. Th e 
corresponding hormone levels followed the changes in the 
histological parameters. Th ese data indicate that the ap-
plication of estradiol to menopausal females may speciﬁ -
cally, in two directions, modify the histological characteris-
tics and secretory activities of diﬀ erent pituitary-hormone 
producing cells.
Key words: female rat, middle age, pituitary cells, es-
tradiol.
SAŽETAK
Starenje kod ženskog pola je biološki proces tokom kojeg 
dolazi do promena u strukturi i funkciji endokrinih ćelija i 
tkiva, a posebnu osetljivost ispoljavaju hipoﬁ zne hormon-
produkujuće ć elije. Pored oslobađajućih hormona hipota-
lamusa i estradiol ostvaruje zapaženu ulogu u regulaciji 
sinteze i sekrecije hipoﬁ znih hormona, a još uvek se koristi 
u terapiji menopauzalnih tegoba. Efekti starenja ili ovari-
jektomije, kao i primene sintetskog estradiola pod tim okol-
nostima su ispitivani na hormon-produkujućim ć elijama 
hipoﬁ ze ženki pacova srednjeg doba (animalni modeli 
menopauze) i to: gonadotropima (FSH i LH), tirotropima 
(TSH), somatotropima (GH), mamotropima (PRL) i korti-
kotropima (ACTH). Sve ć elije su imunohistohemijski bojene 
i histološki analizirane, dok je za određivanje nivoa hormo-
na u krvi korišćena ELISA metoda. Utvrđeno je da starenje 
prouzrokuje različite, uglavnom reduktivne promene volu-
mena, broja i sekrecije hormon-produkujućih ćelija hipo-
ﬁ ze u našim animalnim modelima menopauze, izuzev na 
primeru PRL ćelija čiji je broj značajno povećan, a sekrecija 
intenzivirana. Posle tretmana ženki pacova srednjeg doba 
estradiolom apsolutna i relativna masa hipoﬁ ze je značajno 
poveć ana u poređenju sa kontrolnim ženkama. Histološki 
parametri poput volumena ć elija i volumenske gustine PRL 
i ACTH ćelija su značajno poveć ani u poređenju sa kontrol-
nim vrednostima. Sa druge strane, pomenuti parametri u 
FSH, LH i GH, a u izvesnim slučajevima i TSH ć elijama su 
značajno smanjeni nakon tretmana estradiolom, u poređe-
nju sa kontrolama. Koncentracije odgovarajućih hormona u 
krvi su pratile navedene promene histoloških parametara. 
Ova zapažanja ukazuju da estradiol davan menopauzal-
nim jedinkama ženskog pola može na speciﬁ čan način, dvo-
smerno, modiﬁ kovati histološke karakteristike i sekretornu 
aktivnost različitih hormon-produkujućih ć elija hipoﬁ ze.
Ključne reči: ženke pacova, srednje doba, hipoﬁ zne će-
lije, estradiol
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decrease in circulating estradiol, is a critical factor trigger-
ing the menopausal transition (6), along with the distinctive 
changes at the level of the hypothalamus and anterior pitu-
itary hormone-producing cells in the same individuals (7-8). 
In support of the latter, it was observed that the LH response 
to GnRH is decreased in older females compared with young 
females (7). Simultaneously, alterations in some other hor-
mone-producing cell populations were also found in ageing 
female rats and women (5, 9-11). Despite some risks (12), es-
tradiol replacement represents the classical therapeutic ap-
proach in the prevention of health problems due to ovarian 
hormone deficiency (13, 14). Various animal models have 
been developed to define the space for problematising the 
multiple morphofunctional changes during menopause, as 
well as to solve the present controversies regarding the ap-
plication of estradiol in humans. Our experimental work in 
the field implied the usage of intact middle-aged (14 months 
old) or ovariectomised adult (3 months old) Wistar female 
rats, for which the pituitary histological and hormone se-
creting studies had a central role (10, 11, 15-18). Herein, we 
aim to present the accumulated data regarding the various 
populations of anterior pituitary hormone-producing cells 
in our animal models of menopause and in related studies, 
as well as to elaborate the observed effects of synthetic estra-
diol application in these experimental studies.
Menopausal rat pituitary hormone-producing cells
Ageing is associated with a myriad of anatomical and 
functional changes of the endocrine glands, in the last in-
stance as a result of programmed cell death and also as a con-
sequence of autoimmune-mediated destruction or neoplastic 
transformation of the glandular tissue (19). Commonly, age-
ing represents the critical biological period for the control of 
gene expression and secretory activity in various endocrine 
cells and tissues, as well as in the entire hormone-producing 
cell pool in the pituitary gland (5, 20, 21). Female ageing has 
been our research focus for years, and we exploited intact or 
ovariectomised female rats as a good menopausal model. The 
absolute and relative pituitary weights in our models signifi-
cantly increased by 16.2% and 14.0%, respectively, compared 
with those of intact adult female rats (22).
As mentioned previously, gonadotropes are subjected to 
substantial changes with reproductive ageing in women. Our 
histological analysis of FSH and LH cells in middle-aged fe-
male rats showed that they were both ovoid and polyhedral 
in shape, occurred individually or more frequently in clusters, 
and established close contact with blood vessels (Figure 1 a, c) 
(15). Their nuclei appeared to be round, vesicular and mostly 
eccentric (Figure 1 a, c) (23). In middle-aged female rats, the 
volume of FSH cells was 1375 μm3, and the volume of LH cells 
amounted to 998 μm3. The number of immunolabeled FSH 
and LH cells per unit area (mm2) was 78 and 142, respectively 
(23). Ultrastructural investigations showed that the gonado-
tropes had well-developed rough endoplasmic reticula (RER) 
and Golgi complexes (4). Secretory granules in female go-
nadotropes were spherical or slightly irregular with a small 
INTRODUCTION
Endocrine function realisation is achieved through the 
multi-level systemic organisation, implying the participation 
of the hypothalamus, pituitary gland, immune system and 
various target endocrine organs and tissues. Therefore, the 
pituitary gland represents the entity of special interest be-
cause it orchestrates the immuno-neuro-endocrine interac-
tions by the means of neuronal, hormonal, paracrine, juxta-
crine and autocrine communication (1-2). The anterior part 
of the gland consists of several types of hormone-producing 
cells (gonadotropes - LH  and FSH, thyrotropes - TSH, so-
matotropes - GH, mammotropes - PRL and corticotropes 
- ACTH), as well as folliculo-stellate non-hormone produc-
ing cells (3). Considerable interest has permanently been 
generated regarding hypothalamo-pituitary age-related 
changes. The most common anterior pituitary morphologic 
lesions in ageing involve some hyperplasia or adenoma (4), 
which are pathologies that are strongly linked to reproduc-
tive system function decline (5). Pertinent to this decline, 
ovarian follicular depletion in ageing females, followed by a 
Figure 1. Immunohistochemically labelled pituitary hormone-producing 
cells in menopausal (a – FSH; c – LH, e – TSH, g – GH, i – PRL and k 
– ACTH) and estradiol-treated menopausal (b – FSH, d – LH, f – TSH, 
h – GH, j – PRL and l – ACTH) female rats. Peroxidase-antiperoxidase 
method, bar=16 μm.
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were 1180 μm3, 124 μm3 and 35.8%, respectively (29). Immu-
no-electron-microscopical studies showed that the PRL cells 
have abundant RER and a prominent Golgi complex, which 
contains ovoid or markedly pleomorphic electron-dense se-
cretory granules (4). Importantly, rat PRL cells are divided into 
three subtypes based on the size of the granules (31). Type I 
cells contain large, irregularly shaped secretory granules (300-
700 nm), type II have spherical granules (150-250 nm), and 
type III contain some small round granules (of 100 nm) (31). 
A significant increase in the number of PRL cells and their 
storage secretion was observed in middle-aged female rats by 
Takahashi et al. (1984) and Itoh at al. (2001), who investigated 
their pituitary morphophysiology (36, 37). Takahashi and Ka-
washima (1987) observed a significant age-related increase of 
the DNA content in PRL cells in rats of both sexes; however, 
this increase was more conspicuous in the females than in the 
males (38). Interestingly, age-related differences were signifi-
cant in the relative proportion of each subtype of PRL cells 
(28). Namely, with age, the number of PRL cells with large se-
cretory granules (type I) (31) and the concentration of PRL in 
the blood of female rats increased (5). Ovariectomy decreased 
the volume density of type I PRL cells by 32% but increased 
the same parameter of type II PRL cells by 52% and of type 
III by 16% (28). In ovariectomised female rats, the PRL blood 
levels remain elevated (28).
In our menopausal female rats, immunohistochemically 
labelled pituitary ACTH cells were stellate in shape, pos-
sessed cytoplasmatic processes amongst neighbouring cells 
and resided between the capillaries (Figure 1 k) (17). The 
nuclei followed the cell shape (Figure 1 k) (17). Compared 
to the same cell phenotype in adult female rats, their locali-
sation and shape did not significantly change (39). In other 
studies of female rat ageing, electron microscopy analyses 
of ACTH cells demonstrated that the secretory granules are 
usually numerous, spherical or irregularly shaped (40) and 
have small secretory granules of (150-200 nm) distributed 
mainly at the periphery of the cytoplasm (4). Additionally, 
the RER, Golgi complex and mitochondria appear to be near 
the nucleus (41). Histological and ultrastructural changes 
annotated at the level of ACTH cells during ageing generally 
decrease the sensitivity of the hypothalamo-pituitary system 
to glucocorticoid negative feedback (42).
The effects of estradiol application on pituitary hor-
mone-producing cells in menopausal rats
The synthesis and secretion of pituitary hormones is cen-
trally regulated by hypothalamic-releasing hormones; howev-
er, they are also secreted by some other peripheral hormones. 
Among other things, estradiol is considerably involved in the 
control of various pituitary hormone-producing cells in fe-
male rats (22, 23, 28, 43). Namely, the presence of estradiol in 
the pituitary pars distalis was observed in the nuclei of all of 
the hormone producing cells, including acidophils, basophils 
and chromophobes (44). We have demonstrated previously 
that multiple estradiol doses administered to middle-aged fe-
male rats increase the number of chromophobe and PRL cells 
diameter (200-250 nm) (24). Plasma levels of FSH and LH 
in our middle-aged female rats were 3.67 mU/L and 537.30 
mU/L, respectively (15). In middle-aged female rats, changes 
in pulsatile LH secretion were observed, whereas gonadotro-
phin-releasing hormone (GnRH) could not be detected in the 
peripheral plasma. Therefore, LH may be used as an indirect 
index of GnRH secretion in this age range (25).
TSH cells in middle-aged female rats from our experi-
ments were mainly localised in the ventral or middle portion 
of the anterior pituitary gland (10). These cells adopted a va-
riety of shapes (round, polyhedral or irregular) and had an in-
tensely immunostained cytoplasm (Figure 1 e). Their volume 
density amounted to approximately 15% (10). Specifically, the 
number of TSH cells in middle-aged female rats per unit area 
(mm2) was 110 (10), and their volume decreased with age 
(26). The observed reduction of TSH activity in middle-aged 
female rats is associated with its large molecular form accu-
mulating in the pituitary gland and in blood (27).
Immunohistochemical studies identified GH cells in mid-
dle-aged female rat pituitary glands having ovoid to pyrami-
dal shapes with a spherical, centrally located nucleus. These 
cells were uniformly distributed throughout the gland (Fig-
ure 1 g) (18, 28). In our model of menopause, GH cells were 
usually found situated along the sinusoid capillaries (18). In 
terms of absolute values, the cellular and nuclear volumes 
of the GH cells, and their relative volume density were 1215 
μm3, 61 μm3 and 28%, respectively (29). Morphological anal-
ysis of the GH cells revealed that their heterogeneity rises in 
aged females (30), whereas the number of type II and III of 
GH cells increased with ageing (31). Namely, the type II GH 
cells contained large and small secretory granules, whereas 
the type III GH cells contained only small secretory granules 
(28). At the ultrastructural level, the RER were found dis-
posed in parallel arrays, and the Golgi complex was moder-
ately developed. Lysosomes that were occasionally observed 
in GH cells of acyclic female rats (4, 28, 32) demonstrated that 
the GH secretion declines with ageing and the GH-mRNA 
content decreases due to diminished transcriptional activity 
of the adequate genes (33). The serum GH level decreased in 
middle-aged female rats, which is explained by the increased 
release of somatostatin and the decreased release of growth 
hormone-releasing hormone (GHRH) from the hypothala-
mus (34), as well as with a reduced pituitary responsiveness 
to GHRH stimulation (35). In young female rats, the blood 
GH levels were significantly higher than those of middle-
aged females, whereas the amplitude of GH pulsatile release 
was lower in the middle-aged rats compared with the young 
rats (34). In our model of ovariectomised female rats, the 
GH levels significantly decreased, by 75.8%, compared with 
the intact controls (22).
In the middle-aged female rat pituitary glands we exam-
ined, immunohistochemically labelled PRL cells were polygo-
nal, elongated in shape, had a spherical eccentrically located 
nucleus and and were sporadically distributed in the anterior-
ventral portion of the gland (Figure 1 i) (11). We observed that 
the cellular and nuclear volumes of the PRL cells, and their 
relative volume density in this animal model of menopause 
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(35, 45). Finally, estradiol replacement represents the classical 
therapeutic approach in the prevention of menopausal prob-
lems, although manifesting some risks (12-14). We used the 
above-mentioned menopausal rat models to critically evalu-
ate the effects of synthetic estradiol application, and the fol-
lowing pituitary hormone-producing cell changes were of 
special interest. Primarily, the absolute and relative pituitary 
weights in estradiol-treated middle-aged female rats signifi-
cantly increased by 110% and 123%, respectively, in compari-
son with the control female rats (11). 
The extensive analysis showed that the volume and vol-
ume density of FSH cells, and the FSH blood levels in middle-
aged female rats treated with estradiol-dipropionate (EDP) 
significantly decreased by 35%, 65% and 46%, respectively, in 
comparison with the control values (15, 46). In this animal 
model, the above-mentioned parameters of LH cells signifi-
cantly decreased by 13%, 54% and 55%, respectively, compared 
with the corresponding control values (15, 46). After multiple 
EDP treatments, the FSH and LH cells of middle-aged fe-
males were smaller and pycnotic and exhibited darker immu-
nohistochemical staining in comparison with the untreated 
controls; however, their shape and distribution were not sig-
nificantly altered (Figure 1 b, d) (15, 23). The numbers of FSH 
and LH cells per mm2 significantly decreased after treatment 
with EDP in the same model by 54% and 55%, respectively, 
compared with the control females (23). In ovariectomised 
rats treated with EDP, the number of FSH cells per mm2 was 
6-fold, and the LH cells exhibited a 4-fold decrease in com-
parison with the control values (15). These reduced parame-
ters of the gonadotropes, reflecting, inter alia, their decreased 
content of stored FSH and LH, suggest the suppression of 
their synthetic activity after EDP treatment (45).
In middle-aged female rats treated with EDP, the immu-
nopositive TSH cells were pycnotic and darkly stained (Fig-
ure 1 f ) (10). In the animal model of menopause we used, the 
volume and volume density of the TSH cells significantly de-
creased after treatment with EDP by 44% and 67%, respec-
tively, in comparison with the control females (10). In con-
trast, the relative cellular and nuclear volumes of TSH cells 
increased (by 7% and 30%, respectively) in ovariectomised 
female rats treated with EDP compared with the control 
intact females (47). The observed differences in the immu-
nohistomorphometric characteristics of TSH cells in intact 
and ovariectomised female rats treated with EDP may be the 
result of different administered estradiol doses.
In our EDP-treated menopausal rats, the immunohis-
tochemically stained pituitary GH cells were smaller and ir-
regularly shaped and possessed a strong cytoplasmatic im-
muno-signal compared with the controls (Figure 1 h) (18). 
In these animals, the cellular and nuclear volumes, and the 
relative volume density of the GH cells significantly decreased 
72%, 11% and 86%, respectively, compared with the control 
menopausal females (29). We also observed that estradiol in-
hibits GH secretion up to 65% (28, 29), which reduces sensi-
tivity to GHRH (35). Mooradian (1993) suggested an age-re-
lated decrease in the number of pituitary oestrogen receptors 
(19). Takahashi (1992) demonstrated that estradiol increases 
the percentage of type II and III GH cells (31). These cell types 
contain small secretory granules, a pronounced characteristic 
of the older rat population (31), which may support our re-
sults. Additionally, the GH blood levels after EDP treatment 
in ovariectomised female rats increased by 45% compared 
with intact female rats (21), indicating the significance of the 
removal of the ovaries the outcome of GH secretion.
An increase in the pituitary weight after estradiol treat-
ment was previously observed and is the consequence of 
PRL cell proliferation (48). Murai and Ben-Jonathan (1990) 
postulated that estradiol plays a crucial role in the release 
of PRL (49). The pituitary PRL cells in middle-aged female 
rats after multiple treatments with the EDP are larger in size, 
irregularly shaped and more intensely immunostained com-
pared with the controls (Figure 1 j) (11). The treatment of fe-
male middle-aged rats with EDP significantly increases the 
immunohistomorphometric parameters of their PRL cells, 
especially their volume density (11, 28, 29). Furthermore, 
estradiol application increased the percentage of PRL cells 
with large secretory granules (type I) and decreased the per-
centages of type II and III cells (31). The observed increase 
was consistent with higher serum (11, 29) and pituitary PRL 
levels (50) in rats, which is the biochemical data also found 
in menopausal women (51). The described changes were at-
tributed to the reduction of hypothalamic dopamine activity 
(4). Treatment of ovariectomised, middle-aged female rats 
with 17β-estradiol significantly increased the volume den-
sity of the PRL cells, of which the most numerous were type 
I cells, by 160% compared with the control females (28).
Immunohistochemical analysis of ACTH cells in our 
middle-aged female rats treated with EDP showed that nei-
ther their shape nor their localisation significantly changed 
in comparison with the controls; however, the ACTH cells 
appeared less intensely immunostained (Figure 1 l) (17). In 
parallel, EDP application in the same model significantly 
increased the volume and volume density of ACTH cells by 
10% and 43%, respectively, in comparison with the control 
females (17).
CONCLUSIONS
Our observations of various histological and hormone 
secreting changes in the various hormone-producing cells 
in the ageing or ovariectomised female pituitary gland, as 
well as after synthetic estradiol application, are based on the 
exploitation of the adequate animal models of menopause. 
We have found that ageing causes diverse, commonly reduc-
tive changes regarding the volume, number and secretion of 
menopausal rat pituitary hormone-producing cells, except 
for PRL cells that manifest increased number and intensi-
fied secretion. As expected, after the treatment of middle-
aged female rats with estradiol, the absolute and relative 
pituitary weights significantly increased in comparison with 
the control females. Histological parameters such as the cell 
and volume density of PRL and ACTH cells significantly 
increased compared with control values. In contrast, the 
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mentioned parameters of FSH, LH, GH, and occasionally 
TSH cells after estradiol treatment significantly decreased 
in comparison with the controls. Notably, ovariectomy and 
estradiol treatment in adult female rats caused the increase 
of the TSH cell histological parameters. In general, the cor-
responding hormone level alterations followed the observed 
changes of histological parameters in our models. These 
data indicate that the application of estradiol to menopausal 
females may specifically, in two directions, modify the his-
tological characteristics and secretory activities of various 
pituitary-hormone producing cells.
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